Compounds for the treatment of metabolic disorders

The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes (I).

Saved in:
Bibliographic Details
Main Authors SAMBROOK-SMITH COLIN PETER, JEEVARATNAM REVATHY PERPETUA, SWAIN SIMON ANDREW, STEWART ALAN JOHN WILLIAM, SCHOFIELD KAREN LESLEY, FRY PETER TIMOTHY, FYFE MATTHEW COLIN THOR, BARBA OSCAR, PROCTER MARTIN JAMES, SMYTH DONALD, STONEHOUSE DAVID FRENCH, GATTRELL WILLIAM, KRULLE THOMAS MARTIN
Format Patent
LanguageChinese
English
Published 08.02.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes (I).
Bibliography:Application Number: CN201080011554